Raymond James Financial Services Advisors, Inc. Edap Tms Sa Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$5.3 - $6.3 $1.65 Million - $1.96 Million	-311,424 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$5.52 - $6.97 $1.5 Million - $1.9 Million	-272,550 Reduced 46.67%	311,424 $1.99 Million
Q2 2021 Aug 11, 2021	BUY	$5.88 - $9.54 $2.18 Million - $3.54 Million	371,006 Added 174.21%	583,974 $4.14 Million
Q1 2021 May 14, 2021	BUY	$5.12 - $10.6 $1.09 Million - $2.26 Million	212,968 New	212,968 $1.79 Million

Others Institutions Holding EDAP

# of Institutions

Shares Held

15.6M

Call Options Held

67.6K

Put Options Held

60.9K

Soleus Capital Management, L.P. Greenwich, CT

7.31M
Shares

$17.9 Million
1.58% of portfolio
Morgan Stanley New York, NY

3.37M
Shares

$8.26 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

1.57M
Shares

$3.84 Million
0.14% of portfolio
Archon Capital Management LLC Seattle, WA

1.06M
Shares

$2.6 Million
5.36% of portfolio
Bruce & Co., Inc. Chicago, IL

554K
Shares

$1.36 Million
0.59% of portfolio

View Full List

About EDAP TMS SA

Ticker EDAP
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,145,300
Market Cap $88.6M
Description
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...

More about EDAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account